Related Experiment Video
Updated: May 5, 2026

07:30
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
10.8K
[Five-year application experience of cytological method in dacryological practice].
Vestnik Oftalmologii
|November 23, 2013
Summary
Cytological examination offers an objective method for assessing lacrimal duct conditions like dacryostenosis. This diagnostic tool aids in evaluating treatment effectiveness for various lacrimal system pathologies.
Area of Science:
- Ophthalmology
- Cytopathology
Background:
- Lacrimal duct pathologies, including dacryostenosis, dacryocystitis, and canalicular obliteration, affect a significant number of patients.
- Accurate diagnosis and effective treatment monitoring are crucial for managing these conditions.
Purpose of the Study:
- To evaluate the application and effectiveness of cytological examination in the long-term assessment of patients with lacrimal duct pathologies.
- To determine if cytological examination can be integrated into the standard diagnostic and follow-up algorithms.
Main Methods:
- A long-term study involving 194 patients (288 eyes) with various lacrimal duct conditions.
- Clinical, instrumental, and cytological examinations were performed.
- Conservative treatment for dacryostenosis and surgical interventions (microendoscopic dacryocystorhinostomy, laser dacryocystorhinostomy, microendoscopic canaliculocystorhinostomy) for other conditions were employed.
Main Results:
- Cytological examination was utilized as part of the assessment and to evaluate treatment outcomes.
- The study demonstrated that cytological examination provides objective data.
- The method proved valuable in monitoring the effectiveness of both conservative and surgical treatments.
Conclusions:
- Cytological examination is an objective and valuable method for assessing patients with lacrimal duct pathologies.
- This technique can be reliably incorporated into the diagnostic and follow-up protocols for conditions affecting the lacrimal system.

